Navigation Links
Naviscan Receives CE Mark Approval for High-Resolution Breast PET and PET-Guided Biopsy
Date:9/8/2011

SAN DIEGO, Sept. 8, 2011 /PRNewswire/ -- Naviscan, the leader in organ-specific molecular imaging, announced today that it obtained CE Mark approval for both its high-resolution PET scanner and PET-guided biopsy accessory.  The breast application of the scanner is Positron Emission Mammography (PEM).  Naviscan has expanded its distribution into 13 European countries and has already received its first two orders in Germany and Switzerland.

Naviscan manufactures the only commercially-available, high-resolution PET scanner with PET-guided biopsy system.  The scanner uses PET technology to produce tomographic images that allow physicians to visualize breast tumors with an unprecedented resolution of 1.6 mm, about the width of a grain of rice.  In recently published data, PEM has been found to be significantly more precise than existing technologies at identifying benign and cancerous lesions, in what scientists call "specificity," therefore reducing the number of unnecessary biopsies.  This finding is a welcomed outcome for women and physicians looking for ways to reduce the patient trauma and cost associated with unnecessary procedures.

"CE Mark approval for Naviscan’s technology is a significant accomplishment and we are thrilled that women in Europe can now benefit from our 3-D, high-resolution, molecular breast imaging (MBI) system," stated Paul Mirabella, Chairman and CEO of Naviscan.  "We look forward to continuing to help detect and treat breast cancer on an even greater global scale."

About Naviscan, Inc.

Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the U.S. and other parts of the world. The Company is headquartered in San Diego, California and is the first to obtain both FDA-clearance and CE Mark approval for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance. For more information, call 1.858.587.3641 or visit www.naviscan.com

For more information, including images, videos, quotes and links, please visit the social media news release (SMNR) at http://pitch.pe/171427


'/>"/>
SOURCE Naviscan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng
2. Naviscan Announces Partnership With Chindex Medical Limited for Mainland China, Hong Kong and Macau
3. Naviscan Announces European Launch of Positron Emission Mammography
4. Naviscan® Announces Collaboration With Neoprobe Corporation to Enable Pipeline Technology Development
5. SightLine Health Adds Naviscan PEM Technology to Breast Cancer Treatment Services
6. Naviscan Positron Emission Mammography Technology Highlighted at the Society of Nuclear Medicine Annual Meeting
7. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
8. First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment
9. Baylor Adds Naviscan PEM Technology to Womens Imaging Center
10. MedShape Solutions, Inc. Receives SBIR Phase I Development Grant for Shape Memory Meniscal Repair Device
11. NeuroSigma Receives Notice of Award from NIH for an STTR Grant for its Trigeminal Nerve Stimulation Therapy for Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Research and Markets has announced the addition of the "Menopause Drugs ... ... Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks ... What are the key drugs marketed for ... Menopause market? What are the unit prices and annual ...
(Date:2/23/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs Price ... in the global Oesophageal Cancer market. The research answers ... key drugs marketed for Oesophageal Cancer and their clinical attributes? How ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... Dr. Ronald E. Hawkins, vice president ... of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean ... Dr. Bell comes to Liberty from the Ohio University Heritage College of Osteopathic ...
(Date:2/24/2017)... ... February 24, 2017 , ... In the Health Care IT campaign, Robert Herjavec ... it’s not if you will be attacked, but when.” However, he and many others ... health care. , Improvements in auditing and monitoring have taken security in health care ...
(Date:2/24/2017)... Texas (PRWEB) , ... February 24, 2017 , ... ... to The Medical Center at Craig Ranch building at 8080 State Highway 121, Suite ... Medical District with easy access to Highway 121. , As the practice has grown, ...
(Date:2/24/2017)... ... , ... With ProGlass Prism users now have the ability to simulate prism ... position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, anchor ... Prism users are given the tools and effects to generate a fractal prismatic ...
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... concerning this present generation. Yisrayl makes an astounding statement when he says that ... explains that the Bible details the current times so plainly that anyone should be ...
Breaking Medicine News(10 mins):